Coxam V, Miller M A, Bowman M B, Miller S C
Radiobiology Division, School of Medicine, University of Utah 84112 Salt Lake City, USA.
Arch Physiol Biochem. 1996;104(2):173-9. doi: 10.1076/apab.104.2.173.12893.
The aim of this study was to compare the effect of two cytokines, IGF-I and IGF-II on skeletal development in the rat. The three medial metatarsal rudiments were dissected out from fetuses at days 19, 20 or 21 of gestation and from newborns at days 1, 3, 6 and 9 after birth, then grown in serum-free MEM medium at 37 degrees C and 5% CO2 in air. From day 19 of gestation to the end of experiment, longitudinal bone growth (mm) was significantly increased by IGF-I (2.975 +/- 0.050) and IGF-II (2.530 +/- 0.062), compared to controls (2.188 +/- 0.060). In the same way, the width (mm) at the last experimental day was 0.360 +/- 0.010 in IGF-I- and 0.327 +/- 0.008 in IGF-II-treated bones, respectively (vs 0.313 +/- 0.012 in controls). Mineralization was also stimulated under both growth factors (length of the calcified diaphysis (mm): 0.691 +/- 0.019 in IGF-I- and 0.446 +/- 0.017 in IGF-II-treated bones; vs 0.383 +/- 0.024 in controls). IGF-I and IGF-II (but to a lesser extent) stimulation was due to an increased DNA synthesis (3H-thymidine uptake) as well as protein anabolism (incorporated proline). In addition, cartilage activity (35S captation) and mineralization (45Ca fixed) were involved in the action of these cytokines. An age dependency of bone response to IGFs was pointed out, the effect being higher during the fetal period than after birth. In conclusion, our results raise the possibility that IGF-II, as well as IGF-I, is involved in the control of osteogenesis.
本研究的目的是比较两种细胞因子,即胰岛素样生长因子-I(IGF-I)和胰岛素样生长因子-II(IGF-II)对大鼠骨骼发育的影响。从妊娠第19、20或21天的胎儿以及出生后第1、3、6和9天的新生儿中取出三块内侧跖骨原基,然后在含5%二氧化碳的37℃无血清MEM培养基中培养。从妊娠第19天到实验结束,与对照组(2.188±0.060)相比,IGF-I(2.975±0.050)和IGF-II(2.530±0.062)显著增加了纵向骨生长(mm)。同样,在最后实验日,IGF-I处理的骨骼宽度(mm)为0.360±0.010,IGF-II处理的骨骼宽度为0.327±0.008(对照组为0.313±0.012)。在两种生长因子作用下矿化也受到刺激(钙化骨干长度(mm):IGF-I处理的骨骼为0.691±0.019,IGF-II处理的骨骼为0.446±0.017;对照组为0.383±0.024)。IGF-I和IGF-II(但程度较轻)的刺激作用归因于DNA合成增加(3H-胸腺嘧啶核苷摄取)以及蛋白质合成代谢(掺入的脯氨酸)。此外,软骨活性(35S摄取)和矿化(45Ca固定)也参与了这些细胞因子的作用。研究指出了骨骼对IGFs反应的年龄依赖性,胎儿期的作用比出生后更高。总之,我们的结果提示IGF-II以及IGF-I可能参与了成骨的调控。